Abstract
To assess the role of hepatic function and alcohol on vitamin D metabolism, serum 25-hydroxyvitamin D (25-OHD) levels were measured in 20 healthy nonalcoholic control subjects, 31 “inactive” cirrhotics whose alcoholism was in remission, 8 alcoholic cirrhotics, and 15 alcoholics with normal liver function. Cirrhosis, but not alcoholism, was associated with low serum 25-OHD levels. The aminopyrine breath test (ABT) was performed because aminopyrine, like vitamin D3, is metabolized by hepatic microsomes; the ABT correlated highly (r-0.74,P<0.01) with serum 25-OHD in the inactive cirrhotics. After an intravenous injection of 120 μg vitamin D3, serum 25-OHD rose significantly within 24 hr in 6 healthy controls and 2 patients with celiac disease but not in 6 inactive cirrhotics. The data suggest impaired 25-hydroxylation of vitamin-D impaired in patients with cirrhosis, related predominantly to the degree of hepatic dysfunction.
Similar content being viewed by others
References
Bhattacharya MD, DeLuca HF: The regulation of rat liver calciferol. J Biol Chem 248:2964–2973, 1973
Bhattacharya MD, DeLuca HF: Comparative studies on the 25-hydroxylation of vitamin D3 and dihydrotachysterol. J Biol Chem 248:2974–2977, 1973
Norman AW, Midgett RJ, Myrtle JF, Nowicki HG: Studies on calciferol metabolism I. Production of vitamin D metabolite 4B from 25-OH-cholecalciferol by kidney homogenates. Biochem Biophys Res Commun 42:1082–1087, 1971
Olson EB, DeLuca HF, 25-hydroxycholecalciferol: Direct effect on calcium transport. Science 165:405–409, 1969
Raisz LG, Trummel CL, Simmons H: Induction of bone resorption in tissue culture: Prolonged response after brief exposure to parathyroid hormone of 25-hydroxycholecalciferol. Endocrinology 90:744–751, 1972.
Myrtle JF, Haussler MR, Norman AW: Evidence for the biologically active form of cholecalciferol in the intestine. J Biol Chem 245:1190–1196, 1970
DeLuca HF: VitaminD-1973. Am J Med 0:1–12, 1974.
Kodicek E: The story of vitamin D: From vitamin to hormone. Lancet 1:325–329, 1974
Stanbury SW, Lumb GA, Mawer EB: Osteodystrophy devel oping spontaneously in the course of chronic renal failure. Arch Intern Med 124:274–281, 1969
Bour H, Battest J-P, Schaison G: Relexions sur les troubles du metabolisme phosphocalcique dans les cirrhoses. A propos d'un cas avec osteomalacie dominante et de l'exploration de huit autres cirrhotiques. Presse Med 71:2772–2776, 1963
Collesson L, Grilliat J-P, Mathieu J: L'osteose rarefiante dans les cirrhoses du foie. Presse Med 73:2571–2574, 1965
Meunier P, Dechavanne M, Prost G: L'os des cirrhotiques etudie par lecture quantitative de la biopsie osseuse. Lyon Med 229:1089–1095, 1973
Saville PD: Changes in bone mass with age and alcoholism. J Bone Joint Surg 47A:492–499, 1965
Nillson BE, Westlin NE: Femur density in alcoholism and after gastrectomy. Calcif Tissue Res 10:167–170, 1972
Nilsson BE, Westlin NE: Changes in bone mass in alcoholics. Clin Orthop 90:229–232, 1973
Chalmers J, Conacher WDH, Gardner DL, Scott PJ: Osteomalacia—a common disease in elderly women. J Bone Joint Surg 49B:403–423, 1967
DeLuca HF: Vitamin D: a new look at an old vitamin. Nutr Rev 29:179–181, 1971
Hepner GW, Vesell ES: Quantitative assessment of hepatic function by breath analysis after oral administration of14C-aminopyrine. Ann Intern Med 83:632–638, 1975
Belsey R, Deluca HF, Potts JT: Competitive binding assay for vitamin D and 25-OHD vitamin D. J Clin Endocrinol Metab 33:554–557, 1971
Rosen JF, Roginsky M, Nathenson G, Finberg L: 25-hydroxyvitamin D plasma levels in mothers and their premature infants with neonatal hypocalcemia. Am J Dis Child 127:220–223, 1974
Atkinson M, Nordin BEC, Sherlock S: Malabsorption and bone disease in prolonged obstructive jaundice. Q J Med 25:299–312, 1956
Thompson GW, Lewis B, Booth CC: Absorption of vitamin D3 −3H in control subjects and patients with intestinal malabsorption. J Clin Invest 45:94–102, 1966
Kehayoglou AK, Agnew JE, Holdsworth CD, Whelton MJ, Sherlock S: Bone disease and calcium absorption in primary biliary cirrhosis. Lancet 1:715–718, 1968
Dent CE, Stamp TCB: Theoretical renal phosphorus threshold in investigation and treatment of osteomalacia. Lancet 1:857–860, 1970
Stamp TCB: Intestinal absorption of 25-hydroxycholecalciferol. Lancet 2:121–123, 1974
Avioli LV, Haddad JG: Vitamin D: Current concepts. Metabolism 22:507–531, 1973
Gross JB, Comfort MW, Wollaeger EE, Power MH: Total solids, fat and nitrogen in the feces; study of patients with parenchymatous hepatic disease. Gastroenterology 16:140–150, 1950
Fast BB, Wolfe SJ, Stormont JM, Davidson CS: Fat absorption in alcoholics with cirrhosis. Gastroenterology 37:321–324, 1959
Rasmussen H, Bordier P: Vitamin D—biochemistry and physiology. The Physiological and Cellular Basis of Metabolic Bone Disease. H Rasmussen, P Bordier (eds). Baltimore, Williams and Wilkins, 1974, pp 207–249
Arnaud SB, Goldsmith RS, Lambert P, Go VLW: 25-hydroxyvitamin D3: Evidence of an enterohepatic circulation in man. Proc Soc Exp Biol Med 149:570–572, 1975
Hepner GW: Increased sensitivity of the cholylglycine breath test for detecting ileal dysfunction. Gastroenterology 68:8–16, 1975
Hahn TJ, Birge SJ, Scharp CR, Avioli LV: Phenobarbitalinduced alterations in vitamin D metabolism. J Clin Invest 51:741–748, 1972
Hahn TJ, Hendin BA, Scharp CR, Haddad JG: Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med 287:900–904, 1972
Hahn TJ, Hendin BA, Scharp CR, Boisseau VC, Haddad JG: Serum 25-hydroxycalciferol and bone mass in children anticonvulsants. N Engl J Med 292:550–554, 1975
Author information
Authors and Affiliations
Additional information
This work was supported in part by Grant AM 17303 from the National Institutes of Health.
Rights and permissions
About this article
Cite this article
Hepner, G.W., Roginsky, M. & Moo, H.F. Abnormal vitamin D metabolism in patients with cirrhosis. Digest Dis Sci 21, 527–532 (1976). https://doi.org/10.1007/BF01464758
Issue Date:
DOI: https://doi.org/10.1007/BF01464758